Watch Mark Linthicum’s “101 Course” on IVI’s New Non-Small Cell Lung Cancer Value Model

2019-03-11T17:01:06-06:00March 11th, 2019|IVI News|

IVI’s Director of Scientific Communications, Mark Linthicum, sits down with the Journal of Clinical Pathways for a webinar discussion about IVI’s open-source model for assessing value in non-small cell lung cancer therapies. If you want to learn more about IVI’s open-source approach to value assessment, this webinar is a great place to start.

Click here to view the webinar discussion.